RDPAC药品推广行为准则 - IFPMA
RDPAC药品推广行为准则 - IFPMA
RDPAC药品推广行为准则 - IFPMA
- TAGS
- ifpma
- www.ifpma.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
研<br />
制<br />
开<br />
发<br />
制<br />
药<br />
企<br />
业<br />
协<br />
会<br />
18<br />
其他由前述中国境外研发<br />
类制药企业在中国依法设<br />
立的机构。<br />
见注释1第2段<br />
第二条 互动交流的基本原则<br />
2.1 互动交流的基本原则<br />
会员公司与医疗卫生专业人<br />
士和其他利益相关人士进行互动<br />
交流的目的是造福患者和提高医疗<br />
水平。两者之间的互动交流的重点<br />
应集中在由前者向后者传达药品信<br />
息、提供科学及教育方面的资讯、<br />
以及前者为医学研究和教育提供支<br />
持等方面。<br />
2.2 推广活动的透明度<br />
对于由会员公司赞助的、与药<br />
品及其使用相关的材料,无论其性<br />
质是否属于推广,均应明示该材料<br />
系由某会员公司赞助。会员公司不<br />
得对其推广行为和活动作任何形式<br />
的隐藏或掩饰。<br />
注释7-8<br />
istered in China by such an overseas<br />
R&D-based pharmaceutical<br />
company.<br />
See Paragraph-2 of ANNOTATION 1<br />
Article 2 Basis of Interactions<br />
2.1 Basis of Interactions<br />
Member companies’ relationships<br />
with healthcare professionals and<br />
other stakeholders are intended to<br />
benefit patients and to enhance the<br />
practice of medicine. Interactions<br />
should be focused on informing<br />
healthcare professionals about medicines,<br />
providing scientific and educational<br />
information and supporting<br />
medical research and education.<br />
2.2 Transparency of Promotion<br />
Material relating to pharmaceutical<br />
products and their uses, whether<br />
promotional in nature or not, which<br />
is sponsored by a company, should<br />
clearly indicate by whom it has been<br />
sponsored. Promotion should not be<br />
disguised.<br />
ANNOTATION 7-8
Change language